On April 22, 2025, BioCardia, Inc. entered into a Private Placement agreement to sell 406,818 shares and warrants to qualified investors at $1.905 per share, expecting to raise approximately $775,000 before expenses. The placement is set to close on April 23, 2025, with proceeds aimed at general corporate purposes.